-
The Big Ten Cancer Research Consortium: teaming up to fight cancer
Susan Goodin, Robert S DiPaola & Patrick J Loehrer
Research Update: Clinical Investigation
-
The Big Ten Cancer Research Consortium: teaming up to fight cancer
Susan Goodin, Robert S DiPaola & Patrick J Loehrer
Research Update: Clinical Investigation
-
The Big Ten Cancer Research Consortium: teaming up to fight cancer
Susan Goodin, Robert S DiPaola & Patrick J Loehrer
Research Update: Clinical Investigation
-
The Big Ten Cancer Research Consortium: teaming up to fight cancer
Susan Goodin, Robert S DiPaola & Patrick J Loehrer
Research Update: Clinical Investigation
-
The Big Ten Cancer Research Consortium: teaming up to fight cancer
Susan Goodin, Robert S DiPaola & Patrick J Loehrer
Research Update: Clinical Investigation
-
The Big Ten Cancer Research Consortium: teaming up to fight cancer
Susan Goodin, Robert S DiPaola & Patrick J Loehrer
Research Update: Clinical Investigation
-
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Changhoon Yoo & Yoon-Koo Kang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Changhoon Yoo & Yoon-Koo Kang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Changhoon Yoo & Yoon-Koo Kang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Changhoon Yoo & Yoon-Koo Kang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Changhoon Yoo & Yoon-Koo Kang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Changhoon Yoo & Yoon-Koo Kang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Adaptive designs for Phase II oncology trials
Meinhard Kieser, Stefan Englert, Geraldine Rauch
Commentary: Clinical Investigation
-
Adaptive designs for Phase II oncology trials
Meinhard Kieser, Stefan Englert, Geraldine Rauch
Commentary: Clinical Investigation
-
Adaptive designs for Phase II oncology trials
Meinhard Kieser, Stefan Englert, Geraldine Rauch
Commentary: Clinical Investigation
-
Adaptive designs for Phase II oncology trials
Meinhard Kieser, Stefan Englert, Geraldine Rauch
Commentary: Clinical Investigation
-
Adaptive designs for Phase II oncology trials
Meinhard Kieser, Stefan Englert, Geraldine Rauch
Commentary: Clinical Investigation
-
Adaptive designs for Phase II oncology trials
Meinhard Kieser, Stefan Englert, Geraldine Rauch
Commentary: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Non-inferiority designs and novel antimicrobials
Giorgio Tarchini
Editorial: Clinical Investigation
-
Non-inferiority designs and novel antimicrobials
Giorgio Tarchini
Editorial: Clinical Investigation
-
Non-inferiority designs and novel antimicrobials
Giorgio Tarchini
Editorial: Clinical Investigation
-
Non-inferiority designs and novel antimicrobials
Giorgio Tarchini
Editorial: Clinical Investigation
-
Non-inferiority designs and novel antimicrobials
Giorgio Tarchini
Editorial: Clinical Investigation
-
Non-inferiority designs and novel antimicrobials
Giorgio Tarchini
Editorial: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 3
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 3
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 3
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 3
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 3
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 3
Acknowledgements: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Community-based study highlights the importance of recruiting homeless persons in smoking cessation trials
News and Views: Clinical Investigation
-
Community-based study highlights the importance of recruiting homeless persons in smoking cessation trials
News and Views: Clinical Investigation
-
Community-based study highlights the importance of recruiting homeless persons in smoking cessation trials
News and Views: Clinical Investigation
-
Community-based study highlights the importance of recruiting homeless persons in smoking cessation trials
News and Views: Clinical Investigation
-
Community-based study highlights the importance of recruiting homeless persons in smoking cessation trials
News and Views: Clinical Investigation
-
Community-based study highlights the importance of recruiting homeless persons in smoking cessation trials
News and Views: Clinical Investigation
-
Emerging oral disease-modifying therapies in multiple sclerosis: a review of the latest clinical evidence
Esther V Hobson,Basil Sharrack
Review Article: Clinical Investigation
-
Emerging oral disease-modifying therapies in multiple sclerosis: a review of the latest clinical evidence
Esther V Hobson,Basil Sharrack
Review Article: Clinical Investigation
-
Emerging oral disease-modifying therapies in multiple sclerosis: a review of the latest clinical evidence
Esther V Hobson,Basil Sharrack
Review Article: Clinical Investigation
-
Emerging oral disease-modifying therapies in multiple sclerosis: a review of the latest clinical evidence
Esther V Hobson,Basil Sharrack
Review Article: Clinical Investigation
-
Emerging oral disease-modifying therapies in multiple sclerosis: a review of the latest clinical evidence
Esther V Hobson,Basil Sharrack
Review Article: Clinical Investigation
-
Emerging oral disease-modifying therapies in multiple sclerosis: a review of the latest clinical evidence
Esther V Hobson,Basil Sharrack
Review Article: Clinical Investigation
-
Novel agents in Waldenstrom macroglobulinemia
Ghayas C Issa, Irene M Ghobrial, Aldo M Roccaro
Therapeutic Prospective: Clinical Investigation
-
Novel agents in Waldenstrom macroglobulinemia
Ghayas C Issa, Irene M Ghobrial, Aldo M Roccaro
Therapeutic Prospective: Clinical Investigation
-
Novel agents in Waldenstrom macroglobulinemia
Ghayas C Issa, Irene M Ghobrial, Aldo M Roccaro
Therapeutic Prospective: Clinical Investigation
-
Novel agents in Waldenstrom macroglobulinemia
Ghayas C Issa, Irene M Ghobrial, Aldo M Roccaro
Therapeutic Prospective: Clinical Investigation
-
Novel agents in Waldenstrom macroglobulinemia
Ghayas C Issa, Irene M Ghobrial, Aldo M Roccaro
Therapeutic Prospective: Clinical Investigation
-
Novel agents in Waldenstrom macroglobulinemia
Ghayas C Issa, Irene M Ghobrial, Aldo M Roccaro
Therapeutic Prospective: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation